Jim Simons Reviva Pharmaceuticals Holdings, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q3 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 216,597 shares of RVPH stock, worth $108,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
216,597Holding current value
$108,298% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding RVPH
# of Institutions
50Shares Held
9.74MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...